![Sean Buckley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sean Buckley
Technik-/Wissenschafts-/F&E-Leiter bei
IMMUNOCORE HOLDINGS PLC
Profil
Sean D.
Buckley is Chief Information Officer & Vice President at Immunocore Holdings Plc since 2021.
Former roles include Chief Financial Officer & Senior Vice President at Longevity Health Holdings, Inc. in 2022, Chief Business Officer & Vice President at Castle Creek Biosciences, Inc. from 2019 to 2021, Chief Financial Officer & Vice President at Fibrocell Science, Inc. from 2017 to 2019, and Manager-Information Technology at Toray Advanced Composites UK Ltd. Education includes an undergraduate degree from The University of Hull and an MBA from Robert H.
Smith School of Business.
Aktive Positionen von Sean Buckley
| Unternehmen | Position | Beginn |
|---|---|---|
| IMMUNOCORE HOLDINGS PLC | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2021 |
Ehemalige bekannte Positionen von Sean Buckley
| Unternehmen | Position | Ende |
|---|---|---|
| LONGEVITY HEALTH HOLDINGS, INC. | Finanzdirektor/CFO | 01.09.2022 |
Castle Creek Biosciences, Inc.
 Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Develops gene therapies for patients with skin and genetic diseases | Corporate Officer/Principal | 01.01.2021 |
| FIBROCELL SCIENCE, INC. | Finanzdirektor/CFO | 01.12.2019 |
Toray Advanced Composites UK Ltd.
 Toray Advanced Composites UK Ltd. Chemicals: SpecialtyProcess Industries Manufactures composites for industrial and automotive markets | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Sean Buckley
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
21
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Fibrocell Science, Inc.
 Fibrocell Science, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as an autologous cell and gene therapy company focused on development of personalized biologics to treat rare skin and connective tissue diseases | Commercial Services |
The University of Hull
 The University of Hull Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Robert H. Smith School of Business
 Robert H. Smith School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Toray Advanced Composites UK Ltd.
Toray Advanced Composites UK Ltd. Chemicals: SpecialtyProcess Industries Manufactures composites for industrial and automotive markets | Process Industries |
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Develops gene therapies for patients with skin and genetic diseases | Health Technology |
Immunocore Holdings Plc
 Immunocore Holdings Plc BiotechnologyHealth Technology Operates as a biotechnology company which develops immunotherapies | Health Technology |
Carmell Therapeutics Corp.
 Carmell Therapeutics Corp. Financial ConglomeratesFinance Manufactures cosmetics | Finance |
